Minimed Group, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
MiniMed Group reports Q3 2026 net sales of $790 million, reflecting a 15% increase, alongside a net loss of $111 million driven by restructuring and litigation charges.